CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Additional Paid-in-Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Treasury stock	Total
Beginning balance, shares at Dec. 31, 2022	77,770,588
Beginning balance at Dec. 31, 2022	$ 776	$ 213,956	$ (66,112)	$ (33)	$ (5,982)	$ 142,605
Net Loss			(24,060)			(24,060)
Issuance of common stock, shares	4,312,500
Issuance of common stock	$ 43	68,410				68,453
Options exercised, shares	415,812
Options exercised	$ 5	2,460				2,465
Foreign currency translation				(382)		(382)
Employee stock purchase plan		742				742
Employee stock purchase plan, shares	37,146
Stock-based compensation		6,782				6,782
Ending balance, shares at Jun. 30, 2023	82,536,046
Ending balance at Jun. 30, 2023	$ 824	292,350	(90,172)	(415)	(5,982)	196,605
Beginning balance, shares at Mar. 31, 2023	82,306,873
Beginning balance at Mar. 31, 2023	$ 821	287,286	(76,924)	(132)	(5,982)	205,069
Net Loss			(13,248)			(13,248)
Offering costs associated with public offering		4				4
Options exercised, shares	192,027
Options exercised	$ 3	840				843
Foreign currency translation				(283)		(283)
Employee stock purchase plan		620				620
Employee stock purchase plan, shares	37,146
Stock-based compensation		3,600				3,600
Ending balance, shares at Jun. 30, 2023	82,536,046
Ending balance at Jun. 30, 2023	$ 824	292,350	(90,172)	(415)	(5,982)	196,605
Beginning balance, shares at Dec. 31, 2023	82,825,455
Beginning balance at Dec. 31, 2023	$ 827	298,394	(123,646)	132	(5,982)	169,725
Net Loss			(31,181)			$ (31,181)
Options exercised, shares	473,749					473,749
Options exercised	$ 5	2,873				$ 2,878
Restricted stock vested	$ 1	(425)				(424)
Restricted stock vested (in shares)	135,683
Foreign currency translation				(845)		(845)
Employee stock purchase plan		570				570
Employee stock purchase plan, shares	69,319
Stock-based compensation		6,112				6,112
Ending balance, shares at Jun. 30, 2024	83,504,206
Ending balance at Jun. 30, 2024	$ 833	307,524	(154,827)	(713)	(5,982)	146,835
Beginning balance, shares at Mar. 31, 2024	82,945,411
Beginning balance at Mar. 31, 2024	$ 828	301,459	(141,045)	(965)	(5,982)	154,295
Net Loss			(13,782)			(13,782)
Options exercised, shares	424,999
Options exercised	$ 5	2,575				2,580
Restricted stock vested		(24)				(24)
Restricted stock vested (in shares)	64,477
Foreign currency translation				252		252
Employee stock purchase plan		490				490
Employee stock purchase plan, shares	69,319
Stock-based compensation		3,024				3,024
Ending balance, shares at Jun. 30, 2024	83,504,206
Ending balance at Jun. 30, 2024	$ 833	$ 307,524	$ (154,827)	$ (713)	$ (5,982)	$ 146,835